Neuro Linguistic Programming Pain Levels After Cesarean Delivery

NCT05033405 | Completed

• 1 other identifier: 047213793060212
• Study Type: interventional
• Target: 76
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted to determine the effect of Neuro-Linguistic Programming (NLP) application on post-cesarean section pain levels.

Conditions

Nursing Caries; Pain, Postoperative

Keywords

NLP, cesarean section, postpartum, pain

Outcome Measures

Primary Outcomes (1)

• Examination of inter-and intra-group differences regarding VAS Scores

  A mean total score on the Visual Analogue Scale (VAS). In this assessment, users score their pain from 0 to 10. The scores are interpreted as follows: "0", no pain at all; 1-4, mild pain; 5-6, moderate pain; and 7-10, severe pain. A mean total score on the VAS of four and above indicates postoperative pain.

  Immediately after the completion of the NLP application

Secondary Outcomes (1)

• Distribution of participant characteristics by groups

  20 minutes after the first administration of the VAS

Study Arms (2)

Experimental:Neuro Linguistic Programming

EXPERIMENTAL

One session (20-minute long) of NLP application was performed. The NLP techniques that were employed were representational systems and submodality. In this technique, the sensory, auditory, and kinesthetic feelings of the individual are learned. These emotions are modified by imagining. The NLP application was carried out by a researcher who has a certificate in this field.

Behavioral: NEURO-LINGUISTIC PROGRAMMING (NLP)

control group

NO INTERVENTION

No NLP was applied on the control group patients.

Interventions

NEURO-LINGUISTIC PROGRAMMING (NLP) BEHAVIORAL

● One session (20-minute long) of NLP application was performed. The NLP techniques that were employed were representational systems and submodality. In this technique, the sensory, auditory, and kinesthetic feelings of the individual are learned. These emotions are modified by imagining. The NLP application was carried out by a researcher who has a certificate in this field

Experimental:Neuro Linguistic Programming

Eligibility Criteria

• Age: 19 Years - 42 Years
• Gender Eligibility Details: The mothers who gave birth through cesarean section in the postpartum service of a maternity and children's hospital
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• The study included individuals who
• had a cesarean section,
• were at the 6th to 24th hour postpartum,
• agreed to participate in the study,
• had a cesarean section for the first time,
• did not use patient-controlled analgesia (PCA),
• did not have an additional health problem that may cause pain in the postpartum period, other than cesarean incision pain, and
• could speak and understand Turkish.

You may not qualify if:

• Mothers who wanted to quit on their own will at any stage after being included in the study, had verbal communication problems, had hearing or vision problems, or had previously been diagnosed with a psychiatric illness were excluded from the sample.

Sponsors & Collaborators

• Munzur University: lead

Study Sites (1)

Nursel Alp Dal

Tunceli, 63000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative; Pain

Interventions

Neurolinguistic Programming

Condition Hierarchy (Ancestors)

Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Neurologic Manifestations; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Models, Neurological; Models, Biological; Models, Theoretical; Investigative Techniques; Models, Psychological; Psycholinguistics; Behavioral Sciences; Behavioral Disciplines and Activities

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: SUPPORTIVE CARE
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Asis. Prof.

Model Details: The study was conducted by using a prospective randomized single-blind clinical trial model.

Study Record Dates

• First Submitted: August 18, 2021
• First Posted: September 2, 2021
• Study Start: March 1, 2021
• Primary Completion: June 1, 2021
• Study Completion: June 21, 2021
• Last Updated: September 2, 2021

Record last verified: 2021-08

Locations

TU (1)